Financials data is unavailable for this security.
View more
Year on year Organo Corp grew revenues 13.54% from 132.43bn to 150.36bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 47.57% net income growth from 11.73bn to 17.31bn.
Gross margin | 29.93% |
---|---|
Net profit margin | 12.09% |
Operating margin | 15.55% |
Return on assets | 10.90% |
---|---|
Return on equity | 19.45% |
Return on investment | 17.94% |
More ▼
Cash flow in JPYView more
In 2024, Organo Corp increased its cash reserves by 13.40%, or 2.08bn. The company earned 3.73bn from its operations for a Cash Flow Margin of 2.48%. In addition the company used 1.42bn on investing activities and also paid 641.00m in financing cash flows.
Cash flow per share | 443.87 |
---|---|
Price/Cash flow per share | 15.32 |
Book value per share | 2,229.15 |
---|---|
Tangible book value per share | 2,207.47 |
More ▼
Balance sheet in JPYView more
Current ratio | 2.19 |
---|---|
Quick ratio | 1.94 |
Total debt/total equity | 0.3441 |
---|---|
Total debt/total capital | 0.2556 |
More ▼
Growth rates in JPY
SmartText is unavailable
Div yield(5 year avg) | 1.65% |
---|---|
Div growth rate (5 year) | 41.08% |
Payout ratio (TTM) | 25.52% |
EPS growth(5 years) | 31.16 |
---|---|
EPS (TTM) vs TTM 1 year ago | 55.22 |
More ▼